Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The FDA-approved injection sites for most of these medications include three primary areas: the abdomen, the front of the thighs, and the upper arms (though upper arm injections often require administration by another person)
PMID: 73 CurradoDSaracinoFDe VincenzoFTrunfioFMarinoAKunLet al
Zhang J, Zhang Y, Sun T, Guo F, Huang S, Chandalia M, Abate N, Fan D, Xin H-B, Chen YE
The CV safety of a lower dose of liraglutide (1.8 mg, Victoza, Novo Nordisk) in people with T2D was established in the Liraglutide Effect and Action in Diabetes: Evaluation of CV Outcome Results (LEADER) study, showing a 13% reduction in major CV events over an average of 3.8 years [44]
No, the overall cancer rates are not higher in GLP-1 users
